Clinical trial technology isn’t the barrier to interoperability; the economics are. Two industry leaders explain why nothing forces systems to connect.
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Clinical Trial Governance A Strategic Look At KPIs From An RTSM Perspective
Learn how data-driven metrics improve oversight, mitigate risk, and accelerate execution while safeguarding supply continuity and patient safety.
-
How AI And ML Can Transform Clinical Trial Conduct
There’s no doubt that 2023 will be remembered as the year that artificial intelligence and machine learning became mainstream. Gain an overview of the uses of AI and ML in clinical conduct.
-
RTSM Automating Adaptive Enrollment In Basket Trials
Adaptive basket trials need real-time data to close underperforming cohorts fast. See how automation closes that gap and protects patients.
-
Trends Shaping The Pharmaceutical Industry's Future
Decentralized trials and patient choice are key to expanding study reach. Here, we examine how patient access increases with diverse options and AI-powered connections across health systems and sites.
-
Protocol Amendments And Electronic Consent: Overcoming The Challenges To Reap The Benefits
Learn about some insights that have been gleaned from experience deploying eConsent on diverse trial types around the world.
-
Bringing Clinical Research To The Patient Using Patient-Centric Tech
By fostering daily interactions between patients and technology, these smart hubs offer a sustainable approach to ensuring the success and integrity of clinical trials in an evolving landscape of drug development.
-
Remote Clinical Trial Monitoring: CRA Success In An Era Of Autonomy
As organizations become more skillful in training and monitoring CRAs, the latter can be empowered with greater flexibility and freedom in scheduling and travel.
-
Key Insights From The FDA's DHT Guidance
Check out a summary of the FDA’s guidance Framework for the Use of DHTs in Clinical Trials and what it means for sponsors and investigators using these innovative tools.
-
Consolidating Access Into A Single Platform: A Site CEO's Perspective
By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.
-
Clinical Trials In The Age Of Cost Caps
On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.
RECENT NEWSLETTERS
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads